Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Exchange Rate Effect (2019 - 2023)

AVITA Medical filings provide 5 years of Exchange Rate Effect readings, the most recent being -$1000.0 for Q4 2023.

  • On a quarterly basis, Exchange Rate Effect fell 102.27% to -$1000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$16000.0, a 50.0% increase, with the full-year FY2023 number at -$16000.0, up 38.46% from a year prior.
  • Exchange Rate Effect hit -$1000.0 in Q4 2023 for AVITA Medical, up from -$18000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $127000.0 in Q3 2020 to a low of -$68000.0 in Q1 2020.
  • Median Exchange Rate Effect over the past 5 years was -$3500.0 (2022), compared with a mean of $4071.4.
  • Biggest five-year swings in Exchange Rate Effect: skyrocketed 677.27% in 2020 and later tumbled 143.31% in 2021.
  • AVITA Medical's Exchange Rate Effect stood at $48000.0 in 2019, then tumbled by 35.42% to $31000.0 in 2020, then tumbled by 277.42% to -$55000.0 in 2021, then soared by 180.0% to $44000.0 in 2022, then plummeted by 102.27% to -$1000.0 in 2023.
  • The last three reported values for Exchange Rate Effect were -$1000.0 (Q4 2023), -$18000.0 (Q3 2023), and $2000.0 (Q2 2023) per Business Quant data.